v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Cash Flows from Operating Activities:      
Net loss $ (41,310) $ (18,217) $ (32,021)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 17,764 17,672 16,704
Amortization of operating lease right-of-use assets 6,181 5,039 4,781
Accounts receivable allowances 1,116 1,973 3,711
Stock-based compensation 119,983 88,086 59,895
Change in fair value of contingent consideration 506 (1,027) (3,290)
Deferred income taxes (1,077) 448 (22)
Foreign currency impact from dissolution of subsidiary 799 0 0
Asset impairments 2,560 0 0
Other 185 389 239
Changes in operating assets and liabilities:      
Accounts receivable (13,531) 1,170 (5,138)
Unbilled receivables, current 8,843 (6,162) (2,639)
Prepaid expenses and other assets (53) (8,003) (5,740)
Deferred commissions (9,728) (3,716) (4,066)
Accounts payable and accrued liabilities (4,271) 13,491 9,438
Deferred revenue, net 58,673 35,327 28,261
Operating lease liabilities (7,428) (5,132) (4,266)
Other liabilities 7,635 2,191 1,384
Net cash provided by operating activities 146,847 123,529 67,231
Cash Flows from Investing Activities:      
Purchases of property and equipment (2,140) (1,673) (2,457)
Capitalized internal-use software costs (8,343) (7,370) (6,398)
Business combinations, net of cash acquired (9) (51,832) (10,973)
Purchase of strategic investments (2,990) (2,000) 0
Net cash used in investing activities (13,482) (62,875) (19,828)
Cash Flows from Financing Activities:      
Payments for deferred offering costs 0 0 (781)
Proceeds from stock option exercises 10,366 40,845 30,726
Proceeds from employee stock purchase plan 4,029 4,080 3,431
Payments related to tax withholding for vested equity awards (20,291) 0 0
Payments of contingent consideration and holdback associated with acquisitions (1,669) (3,742) (3,051)
Repurchases of common stock (275,168) 0 0
Net cash (used in) provided by financing activities (282,733) 41,183 30,325
Effect of foreign currency exchange rate changes on cash and cash equivalents (928) 2,902 (343)
Net (decrease) increase in cash, cash equivalents and restricted cash (150,296) 104,739 77,385
Cash, cash equivalents and restricted cash - beginning of period 313,309 208,570 131,185
Cash, cash equivalents and restricted cash - end of period 163,013 313,309 208,570
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:      
Cash and cash equivalents 162,813 313,109 208,370
Restricted cash 200 200 200
Total cash, cash equivalents and restricted cash 163,013 313,309 208,570
Supplemental Disclosures of Cash Flow Information:      
Cash paid for income taxes, net of tax refunds 1,330 3,024 2,184
Non-Cash Investing and Financing Activities:      
Purchases of property and equipment in accounts payable and accrued liabilities 27 583 69
Capitalized internal-use software costs in accounts payable and accrued liabilities 136 938 702
Contingent consideration and acquisition holdbacks in accounts payable, accrued expenses and other liabilities 0 1,134 3,052
Issuance of common stock in connection with a business combination 0 384 0
Stock-based compensation expense capitalized in internal-use software costs, net 2,062 478 0
Unpaid accrued tax withholding for vested equity awards 752 0 0
Unpaid excise tax on repurchases of common stock 1,722 0 0
Accrued transaction cost in advance of closing UBS Credit Agreement $ 339 $ 0 $ 0